Data advance knowledge in metabolic syndrome research.

Discusses an abstract of the study "Management of atherogenic dyslipidemia of the metabolic syndrome: Evolving rationale for combined drug therapy," by Alexander Tenenbaum and colleagues at the Tel Aviv University, and published in the "International Journal of Cardiology". Study design and methods; Objectives and findings of the study.